Systematic Reviews
Copyright ©The Author(s) 2025.
Artif Intell Gastroenterol. Jun 8, 2025; 6(1): 106149
Published online Jun 8, 2025. doi: 10.35712/aig.v6.i1.106149
Table 4 Subgroup analysis of factors affecting adenoma detection rate in artificial intelligence colonoscopy
Ref.
ADR based on endoscopist
Indication for colonoscopy
Baseline ADR < 25%
Baseline ADR ≥ 40%
Screening
Surveillance
Soleymanjahi et al[25]RR: 1.39, 95%CI: 1.18-1.63. Similar improvements in ADR, but data were less stratifiedRR: 1.14, 95%CI: 1.08-1.21. (> 1000 colonoscopies): ADR improved by 19%. (RR: 1.19, 95%CI: 1.11–1.27, P < 0.001, I2 = 24.51%)Significant improvement. RR: 1.21, 95%CI: 1.15-1.28, I2 = 76%Less improvement. RR: 1.14, 95%CI: 1.05-1.24, I2 = 65%
Makar et al[17]Improvement. RR: 1.23, 95%CI: 1.16–1.32, I2 = 0%, P < 0.001Improvement. RR: 1.24, 95%CI: 1.15–1.34, I2 = 45%, P < 0.001Improvement. RR: 1.13, 95%CI: 1.07–1.19, I2 = 15%, P < 0.001Improvement. RR: 1.33, 95%CI: 1.23–1.45, I2 = 42%, P < 0.001
Lee et al[15]No significant improvement. RR: 1.01, 95%CI: 0.84–1.2016% increase in ADR compared to standard colonoscopy, but the result was not statistically significant. RR for ADR: 1.16, 95%CI: 0.83–1.62, I2 = 77%5% increase in ADR but the result was not statistically significant. RR for ADR: 1.05, 95%CI: 0.92–1.19, I2 = 62%
Lou et al[18]Significant improvement. RR: 1.42, 95%CI: 1.28–1.58, I2 = 65%Minimal improvement. RR: 1.12, 95%CI: 1.03–1.22, I2 = 52%
Deliwala et al[40]Significantly improved. AUC: 0.97, 95%CI: 0.96–0.98, P < 0.01Moderate improved. AUC: 0.90, 95%CI: 0.87–0.93, P < 0.01